Tag Archives: IDSY

Top Value Stocks To Watch For 2019

Xact Kapitalforvaltning AB acquired a new stake in DSW Inc. (NYSE:DSW) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 10,467 shares of the company’s stock, valued at approximately $235,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Meadow Creek Investment Management LLC bought a new position in DSW during the fourth quarter worth about $114,000. SG Americas Securities LLC bought a new position in DSW during the first quarter worth about $125,000. Advisors Preferred LLC bought a new position in DSW during the first quarter worth about $139,000. Advisor Group Inc. grew its holdings in DSW by 240.4% during the fourth quarter. Advisor Group Inc. now owns 8,204 shares of the company’s stock worth $176,000 after purchasing an additional 5,794 shares during the period. Finally, Asset Management One Co. Ltd. bought a new position in DSW during the first quarter worth about $195,000. Institutional investors own 95.38% of the company’s stock.

Top Value Stocks To Watch For 2019: Golden Star Resources Ltd(GSS)

Advisors’ Opinion:

  • [By Max Byerly]

    Golden Star Resources Ltd. (NYSEAMERICAN:GSS) was the target of a significant increase in short interest in September. As of September 28th, there was short interest totalling 10,021,831 shares, an increase of 6.9% from the September 14th total of 9,371,344 shares. Based on an average trading volume of 1,038,207 shares, the short-interest ratio is presently 9.7 days. Approximately 4.7% of the company’s shares are sold short.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Golden Star Resources Ltd. (TSE:GSC) (NYSE:GSS) has been given an average recommendation of “Buy” by the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is C$1.48.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Value Stocks To Watch For 2019: Pro-Dex Inc.(PDEX)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine upgraded shares of Pro-Dex (NASDAQ:PDEX) from a hold rating to a buy rating in a research report report published on Thursday.

    Shares of NASDAQ:PDEX opened at $10.30 on Thursday. The firm has a market cap of $43.10 million, a price-to-earnings ratio of 19.04 and a beta of -0.20. Pro-Dex has a one year low of $6.05 and a one year high of $11.00.

  • [By Stephan Byrd]

    Pro-Dex (NASDAQ:PDEX) released its quarterly earnings results on Thursday. The medical instruments supplier reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.16, Bloomberg Earnings reports. Pro-Dex had a return on equity of 13.54% and a net margin of 9.94%.

Top Value Stocks To Watch For 2019: CryoPort, Inc.(CYRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CryoPort (NASDAQ:CYRX) posted its quarterly earnings results on Thursday. The consumer goods maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.03), Briefing.com reports. The company had revenue of $4.02 million during the quarter, compared to the consensus estimate of $3.84 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The company’s revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.10) earnings per share.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CryoPort (CYRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Press coverage about CryoPort (NASDAQ:CYRX) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave media coverage about the consumer goods maker an impact score of 46.4366918065987 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Max Byerly]

    CryoPort Inc (NASDAQ:CYRX) Director Richard J. Berman sold 10,000 shares of the firm’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $14.00, for a total transaction of $140,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Shane Hupp]

    CryoPort (NASDAQ:CYRX) had its price objective lifted by Cowen from $11.00 to $16.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. Cowen currently has an outperform rating on the consumer goods maker’s stock.

  • [By Ethan Ryder]

    CryoPort (NASDAQ: CYRX) and C. H. Robinson (NASDAQ:CHRW) are both transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Top Value Stocks To Watch For 2019: I.D. Systems, Inc.(IDSY)

Advisors’ Opinion:

  • [By Logan Wallace]

    I.D. Systems (NASDAQ: IDSY) and Lumentum (NASDAQ:LITE) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends.

  • [By Logan Wallace]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get I.D. Systems alerts:

    I.D. Systems, Inc. (IDSY) Expected to Announce Quarterly Sales of $12.32 Million (americanbankingnews.com) I.D. Systems, Inc. (IDSY) Expected to Announce Earnings of $0.01 Per Share (americanbankingnews.com) I.D. Systems integrates Keytroller, forms PowerFleet division (mmh.com) I.D. Systems Integrates Keytroller and Forms PowerFleet® Division Focused on Industrial Truck Management Systems (finance.yahoo.com)

    Several analysts have commented on IDSY shares. National Securities started coverage on shares of I.D. Systems in a research note on Monday, August 27th. They issued a “buy” rating and a $8.60 price target on the stock. ValuEngine upgraded shares of I.D. Systems from a “sell” rating to a “hold” rating in a research note on Thursday, June 7th. Finally, Zacks Investment Research downgraded shares of I.D. Systems from a “hold” rating to a “sell” rating in a report on Wednesday, August 15th. Two analysts have rated the stock with a sell rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $9.32.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    xG Technology (NASDAQ: XGTI) and I.D. Systems (NASDAQ:IDSY) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Value Stocks To Watch For 2019: Cardiome Pharma Corporation(CRME)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cardiome Pharma Corp. (NASDAQ: CRME) is expected to post quarterly loss at $0.07 per share on revenue of $6.34 million.

    Quest Resource Holding Corporation (NASDAQ: QRHC) is estimated to post quarterly loss at $0.09 per share on revenue of $24.85 million.

  • [By Logan Wallace]

    Cardiome Pharma Co. (TSE:COM) (NASDAQ:CRME) – Stock analysts at Zacks Investment Research issued their Q2 2018 EPS estimates for Cardiome Pharma in a research note issued on Tuesday, May 22nd. Zacks Investment Research analyst J. Vandermosten anticipates that the biopharmaceutical company will post earnings per share of ($0.26) for the quarter.

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern’s rankings:

    Get Cardiome Pharma alerts:

    Cardiome Pharma Corp (TSE:COM): Should The Recent Earnings Drop Worry You? (finance.yahoo.com) Pacira Pharmaceuticals Gets a Hold Rating from Canaccord Genuity (analystratings.com) As of May, 21 Analysts See $-0.20 EPS for Cardiome Pharma Corp. (CRME) (thecasualsmart.com) Cardiome Pharma Corp. (CRME) stock added 0.33% off its SMA-20 (thestocksnews.com) Cardiome Pharma (CRME) Upgraded to Sell at ValuEngine (americanbankingnews.com)

    Shares of CRME traded down $0.01 during mid-day trading on Wednesday, reaching $2.29. The company’s stock had a trading volume of 730 shares, compared to its average volume of 138,610. The firm has a market cap of $80.20 million, a price-to-earnings ratio of -2.53 and a beta of 0.19. The company has a debt-to-equity ratio of 2.47, a quick ratio of 3.99 and a current ratio of 4.80. Cardiome Pharma has a 52 week low of $2.28 and a 52 week high of $2.30.

Top Value Stocks To Watch For 2019: Masco Corporation(MAS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Masco (MAS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Masco (NYSE: MAS) and Ply Gem (NYSE:PGEM) are both construction companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.

  • [By Stephan Byrd]

    Symphony Asset Management LLC cut its stake in shares of Masco Corp (NYSE:MAS) by 51.9% in the first quarter, HoldingsChannel.com reports. The fund owned 38,006 shares of the construction company’s stock after selling 41,020 shares during the period. Symphony Asset Management LLC’s holdings in Masco were worth $1,537,000 at the end of the most recent reporting period.